Intellectual Property India Publishes Patent Application for 'Polymorph As Protein Kinase Mek Inhibitor, And Preparation Method Therefor And Use Thereof' Filed by Shanghai Kechow Pharma, Inc

MUMBAI, India, Sept. 26 -- Intellectual Property India has published a patent application (202517084469 A) filed by Shanghai Kechow Pharma, Inc, Shanghai, on Sept. 5, for 'polymorph as protein kinase mek inhibitor, and preparation method therefor and use thereof.'

Inventor(s) include Tian, Hongqi; and Huang, Gongchao.

The application for the patent was published on Sept. 26, under issue no. 39/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to a polymorph of a benzothiazole compound as a protein kinase Mek inhibitor, and a preparation method therefor and the medical use thereof."

The patent application was internationally filed on Feb. 07, 2024, under International application No.PCT/CN2024/076655.

Disclaimer: Curated by HT Syndication.